OSTEOARTHRITIS
Assessing intraarticular PRP injection with and without somatropin addition for knee OA treatment
Anesth Pain Med. 2016 Oct 19;6(6):e41719. doi: 10.5812/aapm.4171954 patients with mild (Kellgren-Lawrence grade I-II) knee osteoarthritis were randomized to a platelet-rich plasma injection with or without the addition of somatropin growth hormone. Patients were assessed for outcome on the Western Ontario and McMaster Univerisities Osteoarthritis Index (WOMAC) after 1 and 2 months following injection. Results demonstrated significantly better WOMAC score at 1 month in the PRP plus somatropin group compared to the PRP alone group, though difference between groups in WOMAC score at 2 months was no longer statistically significant.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
